Background: Patients with multiple sclerosis (MS) often report neuropathic pain (NP-MS). The purpose of this study was to assess the efficacy and tolerability of duloxetine as treatment for NP-MS. Methods: In this study, 239 adults with NP-MS (duloxetine = 118, placebo = 121) were randomized to …

READ FULL ARTICLE Curated publisher From Wiley Online Library